Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$803
|
$756B |
12.9x |
30.1x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$193
|
$497B |
5.4x |
14.4x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$230
|
$470B |
7.9x |
18.0x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 285
|
$309B |
4.0x |
10.1x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£126
|
$285B |
4.9x |
14.2x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 104
|
$276B |
5.0x |
12.3x |
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 343
|
$248B |
5.2x |
10.7x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$85
|
$239B |
3.7x |
8.2x |
Thermo Fisher Scientific
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Supplies
|
$539
|
$232B |
5.3x |
21.2x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$299
|
$209B |
5.9x |
11.5x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$187B |
3.0x |
7.6x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$123
|
$172B |
6.0x |
11.6x |
Danaher
|
United States of America |
Medical Devices,
Laboratory Services,
Medical Supplies
|
$209
|
$164B |
6.7x |
21.3x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€86
|
$130B |
2.5x |
8.4x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$44
|
$126B |
2.7x |
7.9x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£16
|
$105B |
2.5x |
7.4x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$417
|
$102B |
8.6x |
22.7x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 219
|
$78.4B |
4.9x |
14.7x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4191
|
$70.2B |
2.4x |
8.9x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$144
|
$69.2B |
7.3x |
16.9x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€27
|
$68.2B |
1.3x |
6.1x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 6881
|
$67.5B |
8.4x |
16.5x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€112
|
$65.5B |
2.7x |
9.4x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$482
|
$61.6B |
18.8x |
131.6x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$578
|
$56.5B |
4.0x |
11.8x |
Jiangsu Hengrui Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 65
|
$55.8B |
12.2x |
41.3x |
UCB
|
Belgium |
Vaccines & Immunotherapies
|
€249
|
$55.6B |
6.9x |
23.3x |
Samsung BioLogics
|
South Korea |
Contract Research & Manufacturing
|
KRW 1117000
|
$55.5B |
14.3x |
32.3x |
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 554
|
$52.9B |
5.8x |
19.6x |
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£4
|
$52.1B |
3.5x |
14.1x |
IDEXX Laboratories
|
United States of America |
Medical Devices,
Laboratory Services,
Healthcare Software
|
$635
|
$51.9B |
12.5x |
36.3x |
IQVIA
|
United States of America |
Contract Research & Manufacturing,
Health Data & Analytics,
Healthcare Software
|
$205
|
$48.3B |
3.0x |
12.8x |
argenx
|
Belgium |
Drug Development & Therapeutics
|
€712
|
$46.8B |
12.7x |
56.5x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3996
|
$46.0B |
3.5x |
16.5x |
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€48
|
$44.3B |
1.7x |
10.3x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1679
|
$42.7B |
6.9x |
24.3x |
Galderma Group
|
Switzerland |
Health & Beauty,
Drug Development & Therapeutics
|
CHF 137
|
$42.3B |
8.5x |
37.3x |
Agilent
|
United States of America |
Laboratory Services,
Medical Devices,
Medical Imaging & Diagnostics
|
$142
|
$42.1B |
6.1x |
21.3x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 66
|
$38.3B |
2.2x |
7.7x |
Wuxi AppTec
|
China |
Contract Research & Manufacturing,
Laboratory Services
|
CNY 96
|
$37.8B |
6.3x |
15.1x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$166
|
$33.8B |
75.1x |
-33.8x |
BeOne Medicines
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 192
|
$33.6B |
6.8x |
142.4x |
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 48
|
$30.2B |
2.7x |
13.0x |
Mettler Toledo
|
United States of America |
Laboratory Services,
Medical Devices
|
$1349
|
$29.9B |
7.6x |
24.1x |
Labcorp
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$286
|
$29.7B |
2.1x |
12.6x |
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 175000
|
$28.7B |
10.0x |
29.2x |
Quest Diagnostics
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$190
|
$27.3B |
2.6x |
12.7x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 8150
|
$26.8B |
1.7x |
7.2x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$25.8B |
1.8x |
6.1x |
Sartorius Stedim Biotech
|
France |
Medical Devices,
Laboratory Services,
Contract Research & Manufacturing
|
€203
|
$25.4B |
7.5x |
25.0x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$143
|
$24.8B |
2.6x |
7.7x |
Natera
|
United States of America |
Genomics & Personalized Medicine,
Medical Imaging & Diagnostics
|
$182
|
$24.1B |
12.0x |
-92.0x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 36
|
$24.1B |
12.2x |
32.7x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1607
|
$23.0B |
1.8x |
8.5x |
Insulet
|
United States of America |
Medical Devices,
Drug Delivery Systems
|
$319
|
$22.7B |
9.0x |
38.2x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$37
|
$22.5B |
7.7x |
8.1x |
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 8
|
$22.3B |
2.2x |
6.5x |
Waters
|
United States of America |
Laboratory Services,
Medical Devices
|
$335
|
$21.1B |
6.8x |
18.9x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 344
|
$19.9B |
49.6x |
353.5x |
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 6622
|
$19.4B |
17.1x |
53.2x |
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 87
|
$18.2B |
11.1x |
111.7x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€10
|
$17.8B |
2.1x |
8.4x |
ICON plc
|
United States of America |
Contract Research & Manufacturing,
Healthcare Software,
Health Data & Analytics
|
$185
|
$17.5B |
2.2x |
10.9x |
Wuxi Biologics
|
Hong Kong |
Contract Research & Manufacturing
|
HKD 35
|
$17.3B |
5.9x |
16.6x |
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 2095
|
$17.3B |
4.8x |
12.9x |
Eurofins Scientific
|
France |
Laboratory Services,
Contract Research & Manufacturing
|
€63
|
$16.7B |
2.0x |
9.0x |
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 196
|
$16.5B |
10.7x |
32.6x |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$433
|
$16.5B |
5.2x |
10.0x |
Illumina
|
United States of America |
Genomics & Personalized Medicine,
Laboratory Services
|
$95
|
$16.1B |
3.8x |
14.1x |
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 433000
|
$15.9B |
108.0x |
197.1x |
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 7
|
$15.6B |
3.5x |
13.2x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$21
|
$15.3B |
N/A |
-42.2x |
Biomerieux
|
France |
Laboratory Services,
Medical Imaging & Diagnostics
|
€110
|
$15.2B |
3.2x |
13.0x |
Medpace
|
United States of America |
Contract Research & Manufacturing,
Medical Devices
|
$528
|
$14.9B |
6.2x |
28.9x |
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€52
|
$14.8B |
5.0x |
13.2x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$88
|
$14.7B |
3.1x |
12.4x |
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$21
|
$14.3B |
3.1x |
16.3x |
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 123
|
$14.2B |
32.0x |
-3486.4x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3584
|
$14.0B |
10.0x |
30.6x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$140
|
$13.4B |
4.9x |
21.5x |
Exact Sciences
|
United States of America |
Medical Imaging & Diagnostics,
Genomics & Personalized Medicine
|
$61
|
$13.3B |
4.3x |
30.2x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1578
|
$13.2B |
4.1x |
16.5x |
Revvity
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics,
Health Data & Analytics
|
$93
|
$13.2B |
4.7x |
15.6x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 27
|
$13.2B |
2.3x |
13.1x |
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 458
|
$13.1B |
48.3x |
-306.6x |
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€180
|
$12.9B |
N/A |
N/A |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 312
|
$12.5B |
4.3x |
11.7x |
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 57
|
$12.3B |
2.1x |
14.8x |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2478
|
$12.2B |
8.0x |
31.4x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$136
|
$12.0B |
2.9x |
11.7x |
Financiere de Tubize
|
Belgium |
Biopharmaceuticals
|
€231
|
$11.9B |
N/A |
N/A |
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$11.7B |
0.3x |
5.2x |
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$55
|
$11.6B |
27.7x |
-24.1x |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1256
|
$11.6B |
3.1x |
12.0x |
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 9
|
$11.6B |
2.9x |
10.5x |
Charles River
|
United States of America |
Contract Research & Manufacturing,
Laboratory Services
|
$179
|
$11.4B |
2.8x |
11.8x |
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€67
|
$11.1B |
5.3x |
14.2x |
Qiagen
|
United States of America |
Laboratory Services,
Medical Imaging & Diagnostics
|
$48
|
$11.0B |
5.3x |
14.4x |
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$73
|
$10.8B |
12.9x |
-26.6x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$10.7B |
1.7x |
5.5x |